Related references
Note: Only part of the references are listed.Platelet Inhibition with Prasugrel and Increased Cancer Risks: Potential Causes and Implications
Victor L. Serebruany
AMERICAN JOURNAL OF MEDICINE (2009)
Involvement of UTP in protection of cardiomyocytes from hypoxic stress
Asher Shainberg et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2009)
Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients
Angela M. Amorini et al.
CLINICAL BIOCHEMISTRY (2009)
Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial
Alan D. Michelson et al.
EUROPEAN HEART JOURNAL (2009)
Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy
Alexander Kulik et al.
EXPERT OPINION ON DRUG SAFETY (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Coronary slow flow phenomenon and risk for sudden cardiac death due to ventricular arrhythmias
Shoaib Saya et al.
CLINICAL CARDIOLOGY (2008)
Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders
Rodrigo A. Cunha et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Safety, tolerability, and initial efficacy of AZD6140, the first reversivle oral adenosine diphosphate receptor antagonist, compared with clopidigrel, in patients with non-ST-segment elevation acute coronary syndrome - Primary results of the DISPERSE-2 trial
Christopher P. Cannon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Dyspnoea after antiplatelet agents: the AZD6140 controversy
V. L. Serebruany et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
Platelet inhibition with prasugrel (CS-747) compared with clopidogrel in patients undergoing coronary stenting: the subset from the JUMBO study
V. L. Serebruany et al.
POSTGRADUATE MEDICAL JOURNAL (2006)
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis:: a double-blind comparison to clopidogrel with aspirin
S Husted et al.
EUROPEAN HEART JOURNAL (2006)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
DL Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
ZM Chen et al.
LANCET (2005)
Effects of aerosolized adenosine 5′-triphosphate vs adenosine 5′-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma
OK Basoglu et al.
CHEST (2005)
Metabolic depression in hibernation and major depression: An explanatory theory and an animal model of depression
JA Tsiouris
MEDICAL HYPOTHESES (2005)
Interstitial purine metabolites in hearts with LV remodeling
AV Gourine et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Antiarrhythmic effects of adenosine on ischemia-induced ventricular fibrillation
U Stark et al.
JOURNAL OF CRITICAL CARE (2001)
Share Paper
